COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,112 Articles (21,576 medRxiv, 7,536 bioRxiv)

Most recent first Previous |  Page 1068: Articles 10671-10680  | Next

Country-level Association of Socioeconomic, Environmental and Healthcare-Related Factors with the Disease-Burden and Mortality Rate of COVID-19
Chowdhury, T., Mahbub, U., Rahman, T.
10.1101/2021.08.22.21262449 — Posted: 2021-08-26
Comparative analyses of all FDA EUA-approved rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation
WELLS, C., Pandey, A., Moghadas, S., Singer, B. H., Krieger, G., Herron, R. J. L., Turner, D. E., Abshire, J. P., Phillips, K. M., Donoghue, A. M., Galvani, A. P., Townsend, J. P.
10.1101/2021.08.23.21262499 — Posted: 2021-08-26
Low risk of SARS-CoV-2 transmission via fomite, even in cold-chain
Sobolik, J. S., Sajewski, E. T., Jaykus, L.-A., Cooper, D. K., Lopman, B. A., Kraay, A. N., Ryan, P. B., Guest, J. L., Webb-Girard, A., Leon, J. S.
10.1101/2021.08.23.21262477 — Posted: 2021-08-26
Infection inhibiting effect of RT-PCR testing-isolation in COVID-19 - a case study of Hiroshima and Fukuoka in Japan -
Maki, K.
10.1101/2021.08.24.21262517 — Posted: 2021-08-26
Evaluation of commercial anti-SARS-CoV-2 antibody assays and comparison of standardized titers in vaccinated healthcare workers.
Saker, K., Escuret, V., Pitiot, V., Massardier-Pilonchery, A., Paul, S., Mokdad, B., Langlois-Jacques, C., Rabilloud, M., Goncalves, D., Fabien, N., Guibert, N., Fassier, J.-B., Bal, A., Trouillet-Assant, S., Trabaud, M.-A.
10.1101/2021.08.24.21262475 — Posted: 2021-08-26
Single-shot rAAV5-based Vaccine Provides Long-term Protective Immunity against SARS-CoV-2 and Its Variants
Liao, G., Fan, x.-x., Lau, H., Liu, Z., Li, C., Xu, Z., Zhang, Y., Qi, X., Li, D., Zhu, Q., Chen, L., ZHOU, H., Zhu, S., Ke, B., Pan, H., Cong, Z., Li, Y., Feng, Q., Lv, Q., Liu, J., Liang, D., Li, A., Hong, W., Li, Y., Bao, L., Zhou, F., Gao, H., liang, s., Huang, B., Wu, M., Qin, C., Ke, C., liu, l.
10.1101/2021.08.23.456471 — Posted: 2021-08-26
Directing an mRNA-LNP vaccine toward lymph nodes improves humoral and cellular immunity against SARS-CoV-2
Francis, D. M., Chen, R., Khorsandzadeh, S., Hu, Q., Lyu, X., Wang, H., Lim, W.-l., Sun, H., Xie, H., Shaabani, N., Ross, R., Cooley, B., Ji, H.
10.1101/2021.08.25.457699 — Posted: 2021-08-25
Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization
Kim, Y., Gaudreault, N. N., Meekins, D. A., Perera, K. D., Bold, D., Trujillo, J. D., Morozov, I., McDowell, C. D., Chang, K.-O., Richt, J. A.
10.1101/2021.08.25.457627 — Posted: 2021-08-25
The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters
Carroll, T., Fox, D., van Doremalen, N., Ball, E., Morris, M. K., Sotomayor-Gonzalez, A., Servellita, V., Rustagi, A., Yinda, C. K., Fritts, L., Port, J. R., Ma, Z.-M., Holbrook, M., Schulz, J., Blish, C. A., Hanson, C., Chiu, C. Y., Munster, V., Stanley, S., Miller, C. J.
10.1101/2021.08.25.457626 — Posted: 2021-08-25
Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain, RBD203-N1 as a COVID-19 Protein Vaccine Candidate
Chen, W.-H., Pollet, J., Strych, U., Lee, J., Liu, Z., Kundu, R. T., Versteeg, L., Villar, M. J., Adhikari, R., Wei, J., Poveda, C., Keegan, B., Bailey, A. O., Chen, Y.-L., Gillespie, P. M., Kimata, J. T., Zhan, B., Hotez, P. J., Bottazzi, M. E.
10.1101/2021.08.24.457518 — Posted: 2021-08-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).